Boothbay Fund Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-26,323
| Closed | -$910K | – | 1253 |
|
|
2025
Q1 | $910K | Sell |
26,323
-32,706
| -55% | -$1.13M | 0.02% | 533 |
|
|
2024
Q4 | $1.62M | Sell |
59,029
-19,122
| -24% | -$525K | 0.04% | 412 |
|
|
2024
Q3 | $1.99M | Sell |
78,151
-6,845
| -8% | -$174K | 0.05% | 429 |
|
|
2024
Q2 | $2.15M | Buy |
84,996
+17,355
| +26% | +$440K | 0.05% | 396 |
|
|
2024
Q1 | $2.09M | Sell |
67,641
-36,724
| -35% | -$1.14M | 0.04% | 410 |
|
|
2023
Q4 | $4.21M | Sell |
104,365
-100
| -0.1% | -$4.04K | 0.11% | 206 |
|
|
2023
Q3 | $2.75M | Buy |
104,465
+15,507
| +17% | +$409K | 0.07% | 319 |
|
|
2023
Q2 | $1.53M | Sell |
88,958
-33,775
| -28% | -$581K | 0.03% | 527 |
|
|
2023
Q1 | $2.03M | Buy |
+122,733
| New | +$2.03M | 0.04% | 547 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 1946 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1973 |
|
|
2022
Q1 | – | Sell |
-107,800
| Closed | -$1.8M | – | 1888 |
|
|
2021
Q4 | $1.8M | Buy |
+107,800
| New | +$1.8M | 0.04% | 429 |
|